Xcout Intel
Novoron Bioscience, Inc.
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Subscribe to see Novoron Bioscience, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Novoron Bioscience, Inc. at a glance
Novoron Bioscience, Inc. is a biotechnology company headquartered in United States. It has raised at least $15.2M across the 2 funding rounds on record. Its most recent funding round raised $12.1M in December 2022. Xcout tracks 10 named people at Novoron Bioscience, Inc., including Ryan McMillian (CFO & Financial Strategy).
Novoron Bioscience, Inc. leadership
- Ryan McMillianCFO & Financial Strategy
- David WeinerExecutive Chairman
- Travis StilesCEO & Co-founder
- Shawn GahrCOO & Co-founder
- Sarah BuschNon-Clinical Translation
- William HoekstraDrug Discovery & Development
4 more named people on record for Novoron Bioscience, Inc., with roles, board committees and tenure — see the full roster →
Novoron Bioscience, Inc. funding rounds
At least $15.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $12.1M | — | |
| SEC Form D filing | $3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Novoron Bioscience, Inc. competitors
A few of Novoron Bioscience, Inc.'s closest competitors — see the full list of competitors and alternatives →
Myrobalan Therapeutics is a pre-clinical biotechnology company headquartered in Medford, Massachusetts, focused on developing oral small molecule therapies for central nervous system and neurodegenerative diseases. The company targets novel mechanisms to create neurorestorative treatments for CNS disorders.
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Bloom Science, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on developing novel central nervous system therapies for neurological and metabolic disorders.
Novus Therapeutics, Inc. is a clinical-stage public biotechnology company headquartered in Irvine, California, focused on the acquisition and development of pharmaceutical and therapeutic products.
Navion Neurosciences, Inc. is a preclinical-stage biotechnology company located in Charlottesville, Virginia, that is developing next-generation, AI-enabled therapies.
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Get Novoron Bioscience, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Novoron Bioscience, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access